Condition: Type2 Diabetes Mellitus · Chronic Kidney Disease · Sponsor: Ono Pharmaceutical Co., Ltd.
To investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of ONO-3310 in healthy Japanese adult male subjects and chronic kidney disease patients with type 2 diabetes mellitus
This description comes directly from the study's public registry record.
Ono Pharmaceutical Co., Ltd. · +18665877745 · clinical_trial@ono-pharma.com
International Clinical Trial Support Desk · +17162141777 · clinical_trial@ono-pharma.com
Always discuss trial participation with your own doctor first.
| Souseikai Hakata Clinic | Fukuoka, Fukuoka, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07619157